Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator

Background: Technosphere(®) insulin (TI), an inhaled human insulin with a fast onset of action, provides a novel option for the control of prandial glucose. We used the University of Virginia (UVA)/Padova simulator to explore in-silico the potential benefit of different dosing regimens on postprandi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Diabetes Technol Ther
मुख्य लेखकों: Visentin, Roberto, Giegerich, Clemens, Jäger, Robert, Dahmen, Raphael, Boss, Anders, Grant, Marshall, Dalla Man, Chiara, Cobelli, Claudio, Klabunde, Thomas
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Mary Ann Liebert, Inc. 2016
विषय:
Original Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5035370/
https://ncbi.nlm.nih.gov/pubmed/27333446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2016.0128
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन